about
Nonpharmacologic management of behavioral symptoms in dementiaDifferential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across EuropePsychotropic medications and the transition into care: a national data linkage study.Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warningsTrends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish contextPatterns and trends in antipsychotic prescribing for Parkinson disease psychosisProfile and variables related to antipsychotic consumption according to dementia subtypes.The effectiveness of national guidance in changing analgesic prescribing in primary care from 2002 to 2009: an observational database studyMortality risk with the use of atypical antipsychotics in later-life bipolar disorder.Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.Risk of mortality among individual antipsychotics in patients with dementiaProtocol for REducing Anti-Psychotic use in residential care-Huntington Disease (REAP-HD): a pilot cluster randomised controlled trial of a multifaceted intervention for health professionalsMovement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based studyAssessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.The Effects of Antipsychotic Quality Reporting on Antipsychotic and Psychoactive Medication Use.A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study.National Trends in Treatment Initiation for Nursing Home Residents With Diabetes Mellitus, 2008 to 2010Use of antipsychotics among older residents in VA nursing homesPrescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases.A critical review of methods to evaluate the impact of FDA regulatory actions.Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Reasons for psychiatric medication prescription for new nursing home residents.Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.Atypical antipsychotic-induced metabolic disturbances in the elderly.Antipsychotic medication use in nursing homes: a proposed measure of quality.Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes.A comparison of risperidone and haloperidol for the risk of ischemic stroke in the elderly: a propensity score-matched cohort analysis.Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review.Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice.Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.Reliability and Validity of the Resistiveness to Care Scale Among Cognitively Impaired Older Adults.Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.Comparative safety and efficacy of pharmacological and non-pharmacological interventions for the behavioral and psychological symptoms of dementia: protocol for a systematic review and network meta-analysis.Trends, correlates, and disease patterns of antipsychotic use among elderly persons in Taiwan.Time trends in antipsychotic drug use in patients with dementia: a nationwide study.Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias.
P2860
Q24598981-4FBBB45A-9DF8-4882-BC5A-42E44EF41F51Q28534696-1FCCDEC8-FB36-475D-9A03-58D637F7490DQ28535299-A7A2F62F-9C5E-491A-ABE0-AD4C33805DC7Q30586082-8A4A8FD7-FA63-48B0-AD66-6125A8E354F3Q33888723-646A44A5-1A71-475F-A07A-FB4F42670597Q33910629-A6B537EB-DF7B-4456-8D60-A8BF40EE53FAQ33957582-8506CDA9-EA0E-43BC-8DC7-3AF577AF2BFFQ34158495-B863EB8C-AB61-4525-9B2B-636C6AB3AAC6Q34367078-94B3EA3C-D344-4AC0-9F08-3F08FA87F02DQ34438066-68FB9C2B-ED1B-4A3A-BEBD-EE9C4A1C77DEQ34452896-7E8F4FAA-B767-4389-9469-5342B65CBCC4Q34634590-A5F48957-3F7A-421A-80CB-20E13422D70EQ34635469-C6346999-A21A-4536-B4C7-C6CE97D7BC8BQ34734083-D4BBEE33-85DB-420B-9F7B-A38A8E628DAEQ35619443-9DB46F22-A3D3-4FA4-B109-E522E8E856CFQ35630897-F006C21C-9096-496F-8544-5FDB6531913CQ35984041-79B9F893-6345-46AD-BC97-587D893FAAC1Q36206447-B37B58DD-4433-466E-99AB-189EA7EEA05FQ36545982-83220C5A-ADE5-4153-9FDC-3757587AB1EDQ37048008-916AF80D-B665-4007-BB46-BB23CB417486Q37104247-79935182-08D2-455D-B11B-607714EAA7FBQ37219314-453F3CC6-20F7-447C-9C3F-7204A1A75D4EQ37301216-005E1BD7-F599-404A-832B-B2B31149C191Q37693772-53FA3DDC-A8A1-4A37-8D96-BC1E4AED567BQ37894111-CFC012D0-F5A1-4568-8FE3-E2237328A62CQ38093726-A6512C4D-1047-4435-A2FC-E823EE08B21AQ38183274-5CE5D8F7-A8C2-435B-8A61-8D361FC9312FQ38197557-95CC6D2B-B83F-4FBB-B68E-C936E27D3F16Q38214498-926687C0-359C-4216-AAA2-DB84602A4356Q38244187-61721BA5-C170-4D67-A8C9-DCCF723D4B7FQ38397919-B044D5C6-0FCF-4E31-988C-29A5C1C596CBQ38646167-B2C4A7BE-40C7-4015-8A96-F90EB15E2E3FQ38691294-8E1283F8-44CB-4ADB-9763-2155B95963AEQ38764962-86CDCE8C-2794-4508-B5EF-119D1E7D92C9Q38806187-81D11035-D211-40A0-91ED-B195E1B647ACQ39051107-126947BE-7E8C-405E-B9D7-57900FC160BFQ40052919-B267FA41-FB51-4F59-9B95-0AEC84B56693Q40211664-62DCA554-4D1A-4574-8171-D72D632C6AD5Q40457871-C6DC7159-A84E-40A9-B8CB-9A36EAF7FB26Q40603961-1F34247F-5427-48EA-8E1A-A953B5A6CDD0
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Trends in antipsychotic use in dementia 1999-2007.
@en
Trends in antipsychotic use in dementia 1999-2007.
@nl
type
label
Trends in antipsychotic use in dementia 1999-2007.
@en
Trends in antipsychotic use in dementia 1999-2007.
@nl
prefLabel
Trends in antipsychotic use in dementia 1999-2007.
@en
Trends in antipsychotic use in dementia 1999-2007.
@nl
P2093
P1433
P1476
Trends in antipsychotic use in dementia 1999-2007.
@en
P2093
Claire Chiang
Dara Ganoczy
Francesca Cunningham
Frederic C Blow
Helen C Kales
Hyungjin Myra Kim
Kara Zivin
Lon S Schneider
Rosalinda V Ignacio
P304
P356
10.1001/ARCHGENPSYCHIATRY.2010.200
P407
P577
2011-02-01T00:00:00Z